These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 17616697

  • 1. Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugate.
    Reddy JA, Westrick E, Santhapuram HK, Howard SJ, Miller ML, Vetzel M, Vlahov I, Chari RV, Goldmacher VS, Leamon CP.
    Cancer Res; 2007 Jul 01; 67(13):6376-82. PubMed ID: 17616697
    [Abstract] [Full Text] [Related]

  • 2. The therapeutic efficiency of FP-PEA/TAM67 gene complexes via folate receptor-mediated endocytosis in a xenograft mice model.
    Arote RB, Hwang SK, Lim HT, Kim TH, Jere D, Jiang HL, Kim YK, Cho MH, Cho CS.
    Biomaterials; 2010 Mar 01; 31(8):2435-45. PubMed ID: 20022105
    [Abstract] [Full Text] [Related]

  • 3. Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue.
    Leamon CP, Reddy JA, Vetzel M, Dorton R, Westrick E, Parker N, Wang Y, Vlahov I.
    Cancer Res; 2008 Dec 01; 68(23):9839-44. PubMed ID: 19047164
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vivo structural activity and optimization studies of folate-tubulysin conjugates.
    Reddy JA, Dorton R, Dawson A, Vetzel M, Parker N, Nicoson JS, Westrick E, Klein PJ, Wang Y, Vlahov IR, Leamon CP.
    Mol Pharm; 2009 Dec 01; 6(5):1518-25. PubMed ID: 19630399
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and biological evaluation of EC140: a novel folate-targeted vinca alkaloid conjugate.
    Leamon CP, Reddy JA, Vlahov IR, Kleindl PJ, Vetzel M, Westrick E.
    Bioconjug Chem; 2006 Dec 01; 17(5):1226-32. PubMed ID: 16984132
    [Abstract] [Full Text] [Related]

  • 8. Preclinical evaluation of EC145, a folate-vinca alkaloid conjugate.
    Reddy JA, Dorton R, Westrick E, Dawson A, Smith T, Xu LC, Vetzel M, Kleindl P, Vlahov IR, Leamon CP.
    Cancer Res; 2007 May 01; 67(9):4434-42. PubMed ID: 17483358
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and biological evaluation of EC72: a new folate-targeted chemotherapeutic.
    Leamon CP, Reddy JA, Vlahov IR, Vetzel M, Parker N, Nicoson JS, Xu LC, Westrick E.
    Bioconjug Chem; 2005 May 01; 16(4):803-11. PubMed ID: 16029021
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
    Ross TL, Honer M, Lam PY, Mindt TL, Groehn V, Schibli R, Schubiger PA, Ametamey SM.
    Bioconjug Chem; 2008 Dec 01; 19(12):2462-70. PubMed ID: 19053298
    [Abstract] [Full Text] [Related]

  • 12. Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate.
    Moon WK, Lin Y, O'Loughlin T, Tang Y, Kim DE, Weissleder R, Tung CH.
    Bioconjug Chem; 2003 Dec 01; 14(3):539-45. PubMed ID: 12757377
    [Abstract] [Full Text] [Related]

  • 13. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
    Chiu SJ, Marcucci G, Lee RJ.
    Anticancer Res; 2006 Dec 01; 26(2A):1049-56. PubMed ID: 16619505
    [Abstract] [Full Text] [Related]

  • 14. Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo.
    Leamon CP, Cooper SR, Hardee GE.
    Bioconjug Chem; 2003 Dec 01; 14(4):738-47. PubMed ID: 12862426
    [Abstract] [Full Text] [Related]

  • 15. Folate-targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug.
    Lu JY, Lowe DA, Kennedy MD, Low PS.
    J Drug Target; 1999 Dec 01; 7(1):43-53. PubMed ID: 10614814
    [Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo activity of the maytansinoid immunoconjugate huN901-N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine against CD56+ multiple myeloma cells.
    Tassone P, Gozzini A, Goldmacher V, Shammas MA, Whiteman KR, Carrasco DR, Li C, Allam CK, Venuta S, Anderson KC, Munshi NC.
    Cancer Res; 2004 Jul 01; 64(13):4629-36. PubMed ID: 15231675
    [Abstract] [Full Text] [Related]

  • 17. Impact of high and low folate diets on tissue folate receptor levels and antitumor responses toward folate-drug conjugates.
    Leamon CP, Reddy JA, Dorton R, Bloomfield A, Emsweller K, Parker N, Westrick E.
    J Pharmacol Exp Ther; 2008 Dec 01; 327(3):918-25. PubMed ID: 18791065
    [Abstract] [Full Text] [Related]

  • 18. [Folate receptor-mediated antitumor drugs].
    Zhao J, Cao SL, Zheng XL, Zhao B.
    Yao Xue Xue Bao; 2009 Feb 01; 44(2):109-14. PubMed ID: 19408677
    [Abstract] [Full Text] [Related]

  • 19. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
    Yoshizawa T, Hattori Y, Hakoshima M, Koga K, Maitani Y.
    Eur J Pharm Biopharm; 2008 Nov 01; 70(3):718-25. PubMed ID: 18647651
    [Abstract] [Full Text] [Related]

  • 20. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV.
    Acc Chem Res; 2008 Jan 01; 41(1):98-107. PubMed ID: 17705444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.